Genetic Ablation of MicroRNA-33 Attenuates Inflammation and Abdominal Aortic Aneurysm Formation via Several Anti-Inflammatory Pathways
Author(s) -
Tetsushi Nakao,
Takahiro Horie,
Osamu Baba,
Masataka Nishiga,
Tomohiro Nishino,
Masayasu Izuhara,
Yasuhide Kuwabara,
Hitoo Nishi,
Shunsuke Usami,
Fumiko Nakazeki,
Yuya Ide,
Satoshi Koyama,
Masahiro Kimura,
Naoya Sowa,
Satoko Ohno,
Hiroki Aoki,
Koji Hasegawa,
Kazuhisa Sakamoto,
Kenji Minatoya,
Takeshi Kimura,
Koh Ono
Publication year - 2017
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.117.309768
Subject(s) - inflammation , microrna , abdominal aortic aneurysm , ablation , aortic aneurysm , medicine , aneurysm , pathology , cardiology , biology , surgery , gene , genetics
Abdominal aortic aneurysm (AAA) is an increasingly prevalent and ultimately fatal disease with no effective pharmacological treatment. Because matrix degradation induced by vascular inflammation is the major pathophysiology of AAA, attenuation of this inflammation may improve its outcome. Previous studies suggested that miR-33 (microRNA-33) inhibition and genetic ablation of miR-33 increased serum high-density lipoprotein cholesterol and attenuated atherosclerosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom